Sept 19 (Reuters) - Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's (MDT.N), opens new tab patent rights in nerve-stimulation ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued written decisions on two ...

July 10 (Reuters) - Medical technology company Medtronic MDT.N must defend itself again from challenges brought by rival Axonics AXNX.O to two of its patents related to nerve-stimulation technology, a ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run afoul of three patents held by the company’s main rival, Medtronic. The ...

Even patent judges sometimes make mistakes. That is the oversimplified takeaway from a patent dispute between Axonics and Medtronic that has been anything but simple. The two companies have been ...

The U.S. Court of Appeals awarded another point to the underdogs in a heated patent war between Medtronic and Axonics over competing sacral neuromodulation technologies used to treat various bladder ...

Axonics gets a new chance to invalidate two Medtronic nerve-stimulation patents Related Medtronic lawsuit scheduled for trial in August The U.S. Court of Appeals for the Federal Circuit said, opens ...